A Real-World Effectiveness of Subcutaneous Immunotherapy on the Cost of Medication, Allergic Rhinitis, and Asthma Exacerbations, as well as Upper Respiratory Tract Infection in Subjects with Allergic Rhinitis with or without Asthma: A Retrospective Pilot Study
<i>Background and Objectives</i>: Real-world studies are limited regarding the effectiveness of SCIT on allergic rhinitis (AR) with and without asthma and the cost of medication in Thailand. Moreover, limited data exist regarding the effectiveness of SCIT on worldwide upper respiratory t...
Saved in:
| Main Authors: | Chaicharn Pothirat, Warawut Chaiwong |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
MDPI AG
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/7ef62442690f445688353b8558164535 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Relevance and Advantages of Intradermal Test Results in 371 Patients with Allergic Rhinitis, Asthma and/or Otitis Media with Effusion
by: David S. Hurst, et al.
Published: (2021) -
Allergen Immunotherapy in Asthma
by: Kazuyuki Nakagome, et al.
Published: (2021) -
Preference for Immunotherapy with Tablets by People with Allergic Rhinitis
by: Tankersley M, et al.
Published: (2021) -
ALLERGEN-SPECIFIC IMMUNOTHERAPY: VACCINES FOR ALLERGIC DISEASES
by: A. S. Fedorov, et al.
Published: (2015) -
Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.
by: Benedikt Fritzsching, et al.
Published: (2022)